SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-23-009464
Filing Date
2023-02-01
Accepted
2023-02-01 21:40:03
Documents
2
Period of Report
2023-01-31

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm235103-3_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm235103-3_4seq1.xml 4 7692
2 EXHIBIT 24 tm235103d3_ex24.htm EX-24 6836
  Complete submission text file 0001104659-23-009464.txt   15939
Mailing Address 399 BINNEY STREET, SUITE 300 CAMBRIDGE MA 02139
Business Address 399 BINNEY STREET, SUITE 300 CAMBRIDGE MA 02139 617-679-9600
Rubius Therapeutics, Inc. (Issuer) CIK: 0001709401 (see all company filings)

IRS No.: 042688109 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O RUBIUS THERAPEUTICS, INC. 399 BINNEY STREET, SUITE 300 CAMBRIDGE MA 02139
Business Address
Appelhans Dannielle (Reporting) CIK: 0001874962 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38586 | Film No.: 23578616